Jon Roffman and Anand Vishwarupe co-wrote this blog post with Sankalp Sethi.
Oncology manufacturers spend more than $4 billion on supporting their sales forces and promoting their therapies to physicians, according to ZS analysis, but with the decision-making process moving away from individual physicians, are manufacturers wasting their efforts?
Read MoreTopics: customer engagement, sales force effectiveness, oncology, HCP, physician, oncology manufacturer, prescribing behaviors, treatment decisions, go-to-market model, localization, provider control
Jon Roffman and Anand Vishwarupe co-wrote this blog post with Sankalp Sethi.
Oncology manufacturers spend more than $4 billion on supporting their sales forces and promoting their therapies to physicians, according to ZS analysis, but with the decision-making process moving away from individual physicians, are manufacturers wasting their efforts?
View All ZS Offices
